Homocysteine, lipoprotein (a): risk factors for coronary heart disease

被引:0
|
作者
Laraqui, A
Bennouar, N
Meggouh, F
Allami, A
El Kadiri, N
Benkouka, F
Azeddoug, H
El Haitem, N
Benomar, A
Fellat, S
Benomar, M
机构
[1] Hop Ibn Sina, Lab Ligue Cardiovasc, Rabat, Morocco
[2] Univ Mohammed 5, UFR Biochim Immunol, Fac Sci, Rabat, Morocco
[3] Univ Hassan II, UFR Biol & Sante, Fac Sci Ain Chock, Casablanca, Morocco
[4] Hop Ibn Sina, Serv Cardiol A, Rabat, Morocco
关键词
homocystein; lipoprotein (a); atherosclerosis; risk factor;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Our data suggest that the hyperhomocysteinemia and/or increased plasma level of lipoprotein Lp(a) are risk factors for coronary heart disease. We investigated 178 patients who underwent complete cardiac examination comprising coronary angiography and biological analysis (CT, HDL-c, LDL-c, TG, and apoAI, apoB, homocystein and Lp(a)). Patients presenting a significant stenosis of the coronary artery (greater than or equal to 50% of the vascular lumen) were considered as cases (113 patients). Those without stenosis or with non-significant stenosis (< 50% of the vascular lumen) were used as controls (65 subjects). Homocysteinemia was significantly higher in cases than in control subjects (8.26 mumol/L (2.34 versus 17.85 (2.34, p < 0.001). A strong association between coronary heart disease and homocystein has been found (Eta<^>2 = 0.76). The OR were 0.16 when homocystein level was lower than 15 mumol/L, and 27.78 when homocystein level was upper than or equal to 15 mumol/L. The RR was 5.16 (95% IC = 3.66-6.66, p < 0.001). Eventhough there was a significant correlation between tabagic impregnation and homocysteinemia (Spermann's rho = 0.37, p < 0.05), there was no interactive effect between these two factors and coronary disease (Wald chi(2) = 0.086, p > 0.05). Therefore, no association was found between homocyteinemia and other coronary heart disease risk factors. The Lp(a) levels were significantly higher in cases than in controls subjects (188 (84 mg/L in control subjects versus 590 (199 in cases, p < 0.001). A stronger relationship was noted between coronary heart disease and Lp(a) (Eta<^>2 = 0.66). The OR were 0.09 when lipoprotein (a) levels were lower than 350 mg/L, and 5,88 when Lp(a) levels were higher than or equal to 350 mg/L. The estimate RR was 6.47 (95% IC = 4.39-8.55, p < 0.001). The level of Lp(a) was positively correlated with the severity of coronary heart disease (Spermann's rho = 0.95, p < 0.001). A weak correlation between Lp(a) and LDL-c was observed (Spermann's rho = 0.12, p = 0.048). But the multivariate analysis didn't show interactive effect between these two factors and coronary disease (chi(2) de Wald = 0.264, p > 0.05). No association was noted between Lp(a) and the others risk factors. Moreover, a positive correlation between the levels of homocystein and those of Lp(a) was found (Spermann's rho = 0.54, p < 0.001). In contrast their effect on coronary heart disease seems to be independant (Wald chi(2) = 2.957, p > 0.05). Thus, these two parameters appear as independant risk factors for coronary heart disease.
引用
收藏
页码:549 / 557
页数:9
相关论文
共 50 条
  • [1] Lipoprotein(a) and coronary heart disease risk
    Marcovina S.M.
    Hegele R.A.
    Koschinsky M.L.
    Current Cardiology Reports, 1999, 1 (2) : 105 - 111
  • [2] Risk prediction - Homocysteine in Coronary Heart disease
    Rao B H.
    Govindaraju V.
    Manjunath C.N.
    Indian Journal of Clinical Biochemistry, 2007, 22 (1) : 18 - 21
  • [3] Homocysteine and Risk of Coronary Heart Disease and Stroke
    Gao, Y.
    CARDIOLOGY, 2009, 114 : 138 - 139
  • [4] Relative importance of risk factors for coronary heart disease - The Hordaland Homocysteine Study
    Igland, Jannicke
    Vollset, Stein Emil
    Nygard, Ottar Kjell
    Gjessing, Hakon Kristian
    Ueland, Per Magne
    Tell, Grethe S.
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2012, 46 (06) : 316 - 323
  • [5] Lipoprotein a (LPa), Fibrinogen and Homocysteine in Patients with Coronary Artery Disease and without Major Risk Factors
    Yousefi, Ahmad A.
    Givtaj, Nozar
    Zavarehee, Abbas
    Sabourizadeh, Navid
    Chizaree, Mohammad R.
    IRANIAN HEART JOURNAL, 2006, 7 (01): : 37 - 39
  • [6] Is homocysteine important as risk factor for coronary heart disease?
    Cesari, M
    Rossi, GP
    Sticchi, D
    Pessina, AC
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2005, 15 (02) : 140 - 147
  • [7] Homocysteine: a reversible risk factor for coronary heart disease
    Chambers, JC
    BIOMARKERS OF DISEASE: AN EVIDENCE-BASED APPROACH, 2002, : 374 - 378
  • [8] Homocysteine and coronary heart disease risk in the PRIME study
    Troughton, J. A.
    Woodside, J. V.
    Young, I. S.
    Arveiler, D.
    Amouyel, P.
    Ferrieres, J.
    Ducimetiere, P.
    Patterson, C. C.
    Kee, F.
    Yarnell, J. W. G.
    Evans, A.
    ATHEROSCLEROSIS, 2007, 191 (01) : 90 - 97
  • [9] Lipoprotein(a) and/or LDL-cholesterol, as risk factors for coronary heart disease in blacks?
    Chuang, CZ
    Hecker, M
    LeGardeur, B
    Lopez-S, A
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 59A - 59A
  • [10] Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease
    Özkan, Y
    Özkan, E
    Simsek, B
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 82 (03) : 269 - 277